BAM Capital as of Sept. 30, 2011
Portfolio Holdings for BAM Capital
BAM Capital holds 30 positions in its portfolio as reported in the September 2011 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 24.4 | $24M | 210k | 113.17 | |
| Pharmasset | 11.7 | $11M | 138k | 82.37 | |
| iShares Russell 2000 Index (IWM) | 9.2 | $9.0M | 140k | 64.25 | |
| Biogen Idec (BIIB) | 8.9 | $8.7M | 93k | 93.15 | |
| Targacept | 6.4 | $6.2M | 413k | 15.00 | |
| Netflix (NFLX) | 5.8 | $5.7M | 50k | 113.28 | |
| Medivation | 5.5 | $5.3M | 313k | 16.97 | |
| Keryx Biopharmaceuticals | 5.2 | $5.0M | 1.7M | 3.00 | |
| Vivus | 4.5 | $4.4M | 542k | 8.06 | |
| Barclays Bk Plc ipth s^p vix | 4.4 | $4.3M | 80k | 53.37 | |
| Elan Corporation | 2.5 | $2.4M | 231k | 10.53 | |
| Research In Motion | 2.1 | $2.1M | 102k | 20.31 | |
| Delcath Sys | 1.9 | $1.8M | 551k | 3.34 | |
| Delcath Sys | 1.8 | $1.7M | 512k | 3.34 | |
| Acorda Therapeutics | 1.2 | $1.2M | 60k | 20.00 | |
| XenoPort | 1.0 | $941k | 161k | 5.86 | |
| United Therapeutics Corporation (UTHR) | 0.8 | $783k | 21k | 37.45 | |
| InterDigital (IDCC) | 0.5 | $521k | 11k | 46.52 | |
| Dendreon Corporation | 0.4 | $386k | 43k | 9.00 | |
| Eli Lilly & Co. (LLY) | 0.3 | $285k | 7.7k | 37.01 | |
| Affymax (AFFY) | 0.3 | $268k | 60k | 4.48 | |
| NPS Pharmaceuticals | 0.2 | $235k | 36k | 6.50 | |
| INC Ventrus Biosciences | 0.2 | $236k | 26k | 9.02 | |
| Inhibitex | 0.2 | $198k | 80k | 2.46 | |
| ACADIA Pharmaceuticals (ACAD) | 0.2 | $164k | 152k | 1.08 | |
| shares Agenus | 0.1 | $129k | 274k | 0.47 | |
| Delcath Systems | 0.1 | $97k | 29k | 3.36 | |
| Genvec | 0.1 | $100k | 35k | 2.86 | |
| BioSante Pharmaceuticals | 0.1 | $68k | 30k | 2.27 | |
| GTx | 0.1 | $52k | 15k | 3.37 |
